Biotechnology News

February 2, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2011.     $ in millions, except EPS amounts  ...

February 2, 2012

LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (NASDAQ:RGDX) announced today that it has entered into purchase agreements with investors to raise more than $7.8 million from the private placement of approximately 5,300,000 newly issued...

February 2, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its third quarter of fiscal 2012, which ended on Dec. 31, 2011. The third quarter results reflect the first full quarter of the combined company, Alkermes...

February 2, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR) today announced that it will report its financial results for the fiscal 2012 first quarter ended December 31, 2011, on Thursday, February 9, 2012 at 4:30 p.m....

February 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that members of the company’s management team are scheduled to present a corporate overview at several upcoming investment conferences. The conference...

February 2, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) announced today results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody (“mAb”) therapy....

February 2, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Thursday, February 23, 2012 at 3:30 p.m. Central Time to discuss the Company’s operating results for its fourth...

February 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences receives allowance to 4th engineered meganuclease patent.

February 2, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: An article with the results of Diamyd Medical's European Phase III study of the antigen-based diabetes therapy Diamyd® has been published in the scientific journal the New England Journal of Medicine....

February 2, 2012

BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Sucampo and Takeda announce today that lubiprostone met the primary endpoint in a phase 3 trial for treatment of OBD in patients with chronic, non-cancer pain excluding those taking methadone...

February 2, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) reported today its sales for the fourth quarter and full year 2011. Fourth quarter and full year 2011 unaudited IFRS consolidated sales     Fourth Quarter  ...

February 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster...

February 1, 2012

SEATTLE--(BUSINESS WIRE)--February 1, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 27, 2012, at 4:30 p.m. ET to review fourth quarter and year-end financial results....

February 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, today announced that the underwriters of...

February 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer elects new member of Board of Directors.

February 1, 2012

--(BUSINESS WIRE)--Covidien:           WHO: Jeffrey Saver, MD SWIFT, Lead Author Professor of Neurology and Director UCLA Stroke Center, David Geffen School of Medicine University of California, Los Angeles   WHAT: Results from the Solitaire with...

February 1, 2012

WASHINGTON--(BUSINESS WIRE)--BIO urged the quick enactment of the PDUFA V agreement which will improve the drug development and review process, advance regulatory science & provide earlier access to breakthrough therapies.

February 1, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) announced today that it will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday February 15, 2012 at 2.00 p.m. Eastern Standard Time and 7.00 p.m. Greenwich Mean...

February 1, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Nortech Systems' expertise with medical device contract manufacturing will be on display at the MD&M West show in Anaheim, Calif.

February 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Leerink Swann 2012 Global Healthcare...

February 1, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Obtains Positive EMA Guidance for Lymphoseek® (Tilmanocept); Plans to Submit Marketing Authorization Application (MAA) to European Medicines Agency (EMA) based on pivotal studies

February 1, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--Sage Science announces launch of BluePippin, a DNA fractionator used in NGS library construction. The system uses pulsed-field electrophoresis to enable fractionation of larger DNA, 1- 50 kb.

February 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its fourth quarter financial results on February 14, 2012 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at...

February 1, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. endocrinologists indicate that they would prescribe Amylin/Alkermes...

February 1, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to inform that news of recent FDA Cancer Drug Approval puts Cannabis...

February 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its fourth quarter 2011 earnings release will be issued after market close on Tuesday, February 7, 2012. Ligand’s President and CEO, John Higgins...

February 1, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chief executive officer. Dr. Compton takes over for Dr. Raymond L. Woosley, C-Path’s...

February 1, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan pharma products in oncology and supportive care, today announced a half-day symposium: "Oncology: key...

February 1, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. cardiologists indicate that they would prescribe Cardiome/Merck’s...

February 1, 2012

CLEVELAND--(BUSINESS WIRE)--Hitachi Medical Systems America (HMSA) and Horizon Medical Services are pleased to announce that they have received Health Canada approval for the SCENARIA 64-slice CT System. SCENARIA offers the latest dose saving...

February 1, 2012

AUSTIN, Texas--(BUSINESS WIRE)--ResearchPoint Global (RPG) announces expanded coverage with Integrated Research Inc. (IRI), a leading provider of clinical research services in Canada.

February 1, 2012

TAMPA, Fla.--(BUSINESS WIRE)--OneMedPlace Research initiates coverage on Biovest International, Inc. and BiovaxID personalized cancer vaccine for non-Hodgkin's lymphoma.

February 1, 2012

STOUFFVILLE, Ontario--(BUSINESS WIRE)--Following Health Canada approval, the Zenith Low Profile AAA Endovascular Graft (Zenith AAA LP) from Cook Medical is now approved and will be launched to physicians in Canada.

February 1, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that it will report its fourth quarter and year 2011 financial results on Monday, February 13, 2012, after the close of financial markets. Following the...

February 1, 2012

BOSTON--(BUSINESS WIRE)--In honor of American Heart Month, Health Dialog today announced it has made its award-winning1 patient decision aid, “Living with Coronary Heart Disease” available to the public for the month of February. The decision aid...

February 1, 2012

CONCORD, Calif. & PETACH-TIKVA, Israel--(BUSINESS WIRE)--Cerus (NASDAQ:CERS) and Ilex BioTech Ltd (TASE:ILX) announce regulatory approval for INTERCEPT Blood System in Israel for the treatment of platelets and plasma intended for transfusion...

February 1, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) has hired investment bankers, Ameritech Advisors, LLC and Aurora Capital, LLC, to help the Company evaluate and explore...

February 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical Announces Formation of Clinical and Technology Advisory Boards

February 1, 2012

DUBLIN--(BUSINESS WIRE)--The Irish Medical Device Association (IMDA) has today published its four year strategy (2012 -2015) for the med-tech sector.

February 1, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of U.S. patent...

February 1, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--Positive Preclinical Results Published in the Experimental Neurology Journal

February 1, 2012

RICHMOND, Va. & SEATTLE, Wash. & COLWORTH, England--(BUSINESS WIRE)--Ampliphi shareholder update, leader in development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, including burns. Raised $2.7m to...

February 1, 2012

FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--Nanostart-holding MagForce AG announces capital increase from authorized capital. The proceeds will be used for the commercialization of the NanoTherm® technology and further clinical development...

February 1, 2012

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that the Company received 510k clearance from the Food and Drug...

February 1, 2012

SEATTLE--(BUSINESS WIRE)--February 1, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that its Board of Directors has elected John H. Johnson to the position of president and chief executive officer (CEO), to succeed Mitchell H. Gold,...

February 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011. Fourth Quarter and Full Year 2011...

February 1, 2012

BOSTON--(BUSINESS WIRE)--Boston-based startup unveils an online community and marketplace streamlining contract research and development by connecting biopharma companies with contract service providers.

February 1, 2012

OSLO, Norway--(BUSINESS WIRE)--Targovax, an oncology biopharma company, today announced that it has secured NOK 13 million (USD 2.2 million) from a consortium to develop a pancreatic cancer vaccine.